$Savara (SVRA.US)$ The company released results from Phase 3...

zine1 commented on a stock · Jun 26 08:51

$Savara(SVRA.US)$ The company released results from Phase 3 IMPALA-2 trial of molgramostim 300 mcg administered once daily by inhalation with a matching placebo for autoimmune pulmonary alveolar proteinosis (aPAP).

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2221 Views

Comment

161Followers

7Following

1089Visitors